NCT00003439View on ClinicalTrials.gov

Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 31, 1998

Primary Completion Date

May 31, 2001

Conditions
Cancer
Interventions
BIOLOGICAL

recombinant interleukin-12

Trial Locations (1)

15213

University of Pittsburgh Cancer Institute, Pittsburgh

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00003439 - Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer | Biotech Hunter | Biotech Hunter